Pauline Wimberger

22PUBLICATIONS
197CO-AUTHORS
Cancer geneticsPredictive and prognostic markersOptical properties of materialsCancer therapy (excl. chemotherapy and radiation therapy)Electrical energy generation (incl. renewables, excl. photovoltaics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Jun 12, 2026
Constitutional <i>BRCA1</i> Promoter Methylation in Patients With Ovarian Cancer: Results of the Observational AGO-TR1 Study.

|Apr 24, 2026
A urinary three-metabolite signature enables non-invasive identification of high-risk ovarian cancer patients.

|Dec 10, 2025
Cerebral organoids expressing mutant actin genes reveal cellular mechanism underlying microcephaly.

Indra Niehaus, Michaela Wilsch-Bräuninger, Felipe Mora-Bermúdez

|Dec 03, 2025
Atezolizumab With Bevacizumab and Nonplatinum Chemotherapy for Recurrent Ovarian Cancer: Final Results From the Placebo-Controlled AGO-OVAR 2.29/ENGOT-ov34 Phase III Trial.

Philipp Harter, Frederik Marmé, Andrés Redondo

|Sep 25, 2024
Impact of metformin, statins, and beta blockers on survival in patients with primary ovarian cancer: combined analysis of four prospective trials of AGO-OVAR and ENGOT/GCIG collaborators.

Dominik Denschlag, Florian Heitz, Jacobus Pfisterer

|Mar 22, 2024
The growth factor EPIREGULIN promotes basal progenitor cell proliferation in the developing neocortex.

Paula Cubillos, Nora Ditzer, Annika Kolodziejczyk

Pageof 4

Frequent Collaborators

6 joint publications

Jalid Sehouli

5 joint publications

Florian Heitz

4 joint publications

Jan Dominik Kuhlmann

3 joint publications

Wieland B Huttner